2016) Survival of patients undergoing surgery for metastatic spinal tumours and the impact of surgical site 2 infection. Journal of Hospital Infection, 94 (1). Survival of patients undergoing surgery for metastatic spinal tumours and the impact of surgical site 2 infection 3 4 RUNNING TITLE 5 SSI and survival in spinal tumour patients 6 7 AUTHORS 8
• The authors, title and full bibliographic details is credited in any copy; • A hyperlink and/or URL is included for the original metadata page; and • The content is not changed in any way.
For more information, including our policy and submission procedure, please contact the Repository Team at: E.mailbox@hud.ac.uk. To assess the impact of SSI on patient survival after surgery for spinal metastases. 32
Methods 33
Demographic, operative and survival data were collected on 152 patients undergoing surgery for 34 spinal metastasis at a large UK tertiary referral centre. American Society of Anesthesiologists (ASA) 35 grade and the Revised Tokuhashi Score (RTS) were determined as measures of health status and 36 prognosis, respectively, at baseline. A semi-parametric Cox proportional hazards survival analysis 37 was used to assess the relationships between covariates and survival. 38
Findings 39
Seventeen patients (11.2%) experienced SSI. Overall, median survival time from operation was 262 40 days (95% CI: 190-334 days) and 12 month survival was 42.1%. RTS (p<0.001; hazard ratio 0.82; 95% 41 confidence interval: 0.76-0.89) and ASA grade (p=0.028; hazard ratio 1.37; 95% confidence interval: 42 1.03-1.82) were significantly associated with survival, with better survival found in patients with 43 higher RTS and lower ASA scores. Infection status was of substantive importance, with better 44 survival in those without SSI (p=0.075). 45
Conclusion 46
Twelve month survival in patients undergoing surgery for spinal metastasis is approximately 42%. 47 RTS and ASA scores can be used as indicators of patient survival either in combination or 48 individually. While SSI has some negative impact on survival, a larger study sample would be needed 49 to confirm whether this is statistically significant. 50
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INTRODUCTION 55
Surgical intervention for patients with metastatic spinal tumours is indicated in patients with pain, 56 instability, or neurological compromise who have a life expectancy exceeding 3 months, according to 57 the National Institute of Health and Care Excellence (NICE) Clinical Guideline 75 1 . Surgery aims to 58 prevent or relieve pain, and symptoms associated with mechanical instability and neurological 59 compromise 2, 3 . Complications which jeopardise the success of the operation are therefore highly 60 undesirable. Surgical site infection (SSI) is one such complication, being the third most commonly 61 occurring healthcare-associated infection (HAI) in England (accounting for approximately 16%). SSI 62 has a significant impact on the management of patients undergoing spinal surgery, the length of 63 time they spend in hospital, and how much money is spent on additional treatment 4 . 64
Although there is little evidence available to demonstrate a direct link between SSI and mortality 65 specifically in spinal tumour patients, it has been suggested that those suffering SSI as a result of 66 several types of procedure are overall twice as likely to die and 60% more likely to spend time in the 67 intensive care unit 5 . Determining the risk of SSI and its potential impact on mortality in patients 68 undergoing specialist surgical treatment will further highlight the importance of this complication 69 and the need to implement preventative measures. 70 A significant proportion of patients presenting with spinal metastases are unaware that they have a 71 primary tumour, with symptoms of spinal cord compression being the first indication of the disease. 72
Others, however, are known to be suffering from cancer and receiving treatment. Baseline health 73 status for those undergoing surgery can vary substantially between patients. The Revised Tokuhashi 74 Score (RTS) is a published system recommended by NICE as a tool to determine eligibility for surgery, 75
as it is a recognised as being able to accurately predict survival 6 . However, some healthcare 76 providers do not use the RTS to strictly determine which patients should be offered an operation 77 because not all have a bone scan or a staging computed tomography (CT) pre-operatively, and 78 because of the perceived palliative benefits of surgery even in those who might have a life 79 expectancy less than three months. Generally, the RTS suggests that those with a score of 8 or less 80 have a predicted survival of up to 6 months, meaning that conservative or palliative treatments are 81 indicated. Those with scores of 12 to 15 have a predicted survival of more than 12 months, meaning 82 that excisional surgery may be appropriate. Those with a RTS from 9 to 11 are more often suitable 83 for palliative surgery rather than excisional surgery. Given that RTS appears to be useful in 84 predicting outcomes for patients with spinal metastasis, this score could be used to standardise 85 patients at baseline (i.e. the time of their operation) when investigating whether there is an 86 association between SSI and mortality. Similarly, the American Society of Anesthesiologists (ASA) 87 grade is a recognised scoring system which can be used to determine patient fitness for surgery 7 . 88 ASA grade is relatively more simple than the RTS to determine, and is routinely recorded prior to 89 surgery in the majority of cases. Its use is also recommended by NICE in determining the 90 appropriateness of surgery for patients with spinal tumours. 91 Therefore, the aim of this study was to assess the impact of SSI on patient survival following surgery 92 for spinal metastatic tumours, after controlling for baseline fitness using both RTS and ASA grades. 93 94 95
METHODS 96
This was a sub-study of an ethically approved case note review of all adult patients (aged ≥18 years) 97 who had undergone surgical treatment for spinal metastatic tumours at Salford Royal NHS 98 Foundation Trust (SRFT) between 1 st January 2009 and 31 st December 2012 8 . Demographic (age, 99 sex), operative (date of operation, type of procedure, presence or absence of SSI) and survival data 100
(date of death, if applicable) were collected. Final follow up assessment was conducted on 15 th July 101 2014. In addition, the RTS was determined retrospectively using available medical records and ASA 102 grade was obtained from the surgical documentation. RTS and ASA were determined to give an 103 indication of health status at baseline (i.e. the time of surgery). 104
Definition of SSI 105
The presence or absence of a SSI (superficial or deep) was defined using the criteria set out by Public 106
Health England 9 , which is largely based on the definitions published by the Centers for Disease 107
Control and Prevention (CDC) and the work of Horan et al. 10 . SSIs were classified by the SSI 108 surveillance nurse for the neurosurgery department, as per standard routine for the reporting of SSIs 109 through the hospital SSI Surveillance Service. 110
Data Collection 111
Data were collected from existing patient case notes and associated medical records (e.g. medical 112 images) and were anonymised prior to analysis; no contact with patients or relatives was required 113 for additional data collection. RTS was calculated based on relevant clinically available data; ideally, 114 RTS would be determined pre-operatively in order that this score can be used to assist in assessing 115 patients' suitability for surgery. However, RTS is not formally recorded routinely at our institution 116 and so this score was determined retrospectively based on the method described by Tokuhashi et al. 117 6 where possible, with the exception of instances where the number of extra-spinal bony metastases 118 was unavailable from bone scintigraphy or magnetic resonance imaging (MRI). In these cases, 119
staging CT was used. ASA grade was recorded directly from the surgical pathway documentation. 120
All patients were followed up at at least one year post-surgery. Data relating to infection status and 121 survival were collected at this time point. 122
Statistical Analysis 123
Overall survival was assessed using the Kaplan-Meier method. A semi-parametric Cox proportional 124 hazards survival (time-to-event) analysis was undertaken to assess the relationships between 125 covariates and survival. 126
RESULTS 128
A total of 152 patients (77 females and 75 males) underwent surgery for spinal metastasis over the 129 four year study period. Mean age at operation was 60.5 years (SD 12.9 years). Seventeen patients 130 (11.2%) experienced SSI (14 superficial and 3 deep). At the time of last follow up, 117 patients had 131 died. Median survival time from operation for the whole cohort was 262 days (95% CI: 190-334 132 days). This equates to 42.1% at 12 months, and 19.6% at five years. Median survival time for 133 patients experiencing SSI was 135 days (95% CI: 62-208 days), and for those without infection, 276 134 days (95% CI: 183-369 days). 135
The assumption of proportional hazards was found to be tenable, and measures of patient fitness 136
were not excessively correlated. The Cox analysis found both RTS and ASA score to be significantly 137 associated with survival (Table 1) , with better survival found in patients with higher RTS and lower 138 ASA scores. 139
Direction of approach was not considered as a candidate factor due to only one patient with an SSI 140 experiencing an anterior approach, and less than 10% of patients in total experiencing an anterior 141 approach. Hence direction of approach does not adequately distinguish between either cases, or 142 between controls and was thus unsuitable as a candidate variable. All cases (infection and non-143 infection) were instrumented and so this too was not included in the analysis. The results of this study suggest that the median length of survival from the date of surgery for 161 spinal metastases is approximately 8.6 months. This is comparable to figures previously reported in 162 the literature 11, 12 . Twelve month survival in the present cohort was 42.1% overall (29.4% in those 163 with SSI and 43.7%in those without SSI. 164
As expected, both ASA grade and RTS predicted survival effectively in patients in this study. When 165 using these scores to control for baseline health status, patients experiencing SSI survived on 166 average half as long as those without SSI (though the association between infection and survival was 167 substantive). The low number of cases represented in this study may be a limiting factor and a 168 reason why this association was not observed to be significant. Nevertheless, this study describes 169 the contemporary SSI rate in this patient group at a large UK specialist spinal centre, and is one of 170 the first to demonstrate a relationship between SSI and mortality in this type of patient. 171
It has been estimated that between 38 and 75% of deaths in patients with SSI are attributable to 172 infection itself 13, 14 , with SSI being an independent predictor of mortality. Other studies have 173 suggested that the type of surgery, and whether SSIs are deep/organ space have some bearing on 174 the level of contribution of infection towards death 15 . While this seems logical, it is impossible in 175 this study to indicate whether the type of infection (superficial or deep) had any effect on survival, 176
given that only three cases were documented as being deep. A larger case series would be needed 177 to determine whether additional factors such as this played an important role in affecting survival 178 outcome. 179
It is suggested that there are approximately 4,000 cases of metastatic spinal cord compression 180
diagnosed each year in England and Wales 1 , though this is likely to be an underestimate. Surgery is 181 generally undertaken as a palliative measure to relieve pain and stabilise the spine to prevent 182 further neurological damage. Estimating that only around 20% of these will undergo surgery 183 (Richards, personal communication), and based on the 11.2% infection rate demonstrated in this 184 study, 90 patients per year could be at risk of developing SSI. Given the differential in life expectancy 185 demonstrated in this study between patients with and without SSI (141 days shorter in SSI patients), 186 theoretically, this equates to approximately 12,600 days (34.5 years) of life lost which relates to the 187 onset of SSI for just those treated surgically over the period of one year. This, coupled with the 188 distressing consequences of infection (prolonged in-patient hospitalisation, isolation away from 189 home, additional treatments) and the inevitable economic costs associated with SSI 4 , can be 190 exceedingly frustrating for a service under pressure to provide better care at a lower cost. 191
Scrupulous peri-operative practice and the standardisation of effective processes in the operating 192 theatre may go some way to improving outcomes in terms of SSI rates [16] [17] [18] . In addition, effective 193 surgical work-up and the notion of 'prehabilitation' in the pre-operative period may better prepare 194 some elective spinal surgery patients physiologically to improve some outcomes 19 . However, there 195 is little evidence to support this approach in reducing post-operative complication rate. 196 Furthermore, in urgent cases -such as those needing surgery for spinal tumours -this window of 197 opportunity is generally not available to the care team, meaning that extra preventative measures 198 are highly desirable and clearly warranted. This is especially so in cancer patients given that they are 199 at increased risk of SSI, due largely to their immunosuppressed state 20, 21 . 200 The results provided by this study may be useful during the consenting process for spinal surgery. 201
The appropriateness and quality of information patients receive prior to their operation, about the 202 procedure and its associated risks are of utmost importance when ensuring their decisions are fully 203 informed and their expectations managed. Thus, patients have a right to know about the 204 implications of SSI. Despite this, it is evident from previous studies that many patients are poorly 205 informed about SSIs; some are unable to recognise the signs and symptoms of an infection or 206 unaware of the causes or the risk factors of SSI 22 . This low level of awareness about SSI, coupled 207 with the potential for such devastating effects on quality of life and clinical outcome indicates that 208 greater attention should be paid to this complication across the board. Statistics relating to 209 individual departments, such as those presented in this study, could go some way to educating both 210 staff and patients of the institution, in an effort to emphasise risk factors for SSI, what can be done 211 to combat them, and the importance of their consequences. It is hoped this would then translate 212 into the adoption of processes -on the part of both patient and care team -which drive down the 213 incidence of SSI. 214 215 CONCLUSIONS 216
One-year survival in patients undergoing surgery for spinal metastases is approximately 42%. Either 217 or both of RTS or ASA scores can be used as reliable indicators of survival in these patients. While SSI 218 has some negative impact on survival, a larger study sample would be needed to confirm that this is 219 a statistically significant association. The evidence provided by this study may raise awareness of the 220 importance of SSI as a complication of surgery for spinal metastasis. 221
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